FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.

Saved in:
Bibliographic Details
Title: FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
Authors: Sullivan PM; Seattle Children's Research Institute, Seattle, Washington., Kumar R; Seattle Children's Research Institute, Seattle, Washington., Li W; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Hoglund V; Seattle Children's Research Institute, Seattle, Washington., Wang L; Seattle Children's Research Institute, Seattle, Washington., Zhang Y; Seattle Children's Research Institute, Seattle, Washington., Shi M; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Beak D; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Cheuk A; NCI, CCR, National Institutes of Health, Bethesda, Maryland., Jensen MC; Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Seattle Children's Therapeutics, Seattle, Washington., Khan J; NCI, CCR, National Institutes of Health, Bethesda, Maryland., Dimitrov DS; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Orentas RJ; Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Oct 07; Vol. 21 (10), pp. 1608-1621.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-22-0059